期刊文献+

2009年至2011年住院患者口服抗高血压药品应用分析 被引量:4

Analysis on Oral Antihypertensive Drugs Used in Inpatients of a Hospital during 2009-2011
下载PDF
导出
摘要 目的了解住院患者口服抗高血压药物的应用现状,为临床合理用药及科学管理提供参考。方法以限定日剂量(DDD)法,统计医院住院药房2009年至2011年口服抗高血压药物用药数量、销售金额、用药频度(DDDs)、日均治疗费用(DDC)及销售金额序号与DDDs序号的比值,分析临床用药情况。结果钙离子通道阻滞剂(CCB)、血管紧张素Ⅱ受体拮抗剂(ARB)、血管紧张素转换酶抑制剂(ACEI)在销售金额占前3位,CCB类药物DDDs最大,销售金额最高,应用最广泛,社会效益与经济效益同步。结论CCB,ARB和ACEI在医院住院患者口服抗高血压用药中占主导地位。 Objective To investigate and analyze the utilization status as to provide reference for clinical use and scientific management of of oral antihypertensive drugs in the inpatient of our hospital so this kind of drug. Methods The utilization status of oral antihy-pertensive drugs in our hospital were analyzed statistically based on DDD methods,drugs use quantity,sales sum,DDDs,DDC and the amount of sales order number/DDDs order number. Results The top 3 drugs in terms of the sales sum were calcium channel blocker (CCB),angiotensin II receptor antagonists (ARB) and angiotensin converting enzyme inhibitors(ACEI). CCB showed the highest DDDs and sale sum. CCB was the most widely used among these kinds oral antihypertensive drugs. CCB' s social Results were accord with economic benefits. Conclusion CCB,ARB and ACEI occupy a predominant place in oral antihypertensive drugs in the inDatients of our hospital.
机构地区 辽宁省沈阳市第
出处 《中国药业》 CAS 2012年第24期81-83,共3页 China Pharmaceuticals
关键词 口服抗高血压药 限定日剂量 用药频度 日均治疗费用 oral antihypertensive drug DDD DDDs DDC
  • 相关文献

参考文献4

二级参考文献12

  • 1曲彩红,杨莉,陶玲,朱惠敏,张永明,师晓嘉.2000年~2003年广东地区44家医院降糖药利用分析[J].中国药房,2005,16(1):42-44. 被引量:34
  • 2张继春,金岩,李大魁,彭名炜.北京地区主要抗生素使用频度分析[J].中国药学杂志,1994,29(6):373-376. 被引量:34
  • 3刘屏,张志萍,陈宜鸿,孙映和,颜青,李辉.我院门诊处方中抗菌药物使用研究[J].中国药房,1995,6(2):23-24. 被引量:15
  • 4郑琰,盛蓉,范世忠.我院2001~2004年口服抗糖尿病药物应用分析[J].药品评价,2005,2(5):366-368. 被引量:6
  • 5夏金彪.中国成为糖尿病第二大国,跨国药企挖掘胰岛素市场[N].中国经济时报,2004-11-17.
  • 6The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic:the Antihypertensive and lipid lowering treateeat to prevent Heart A Rack Trial(ALLHAT)[J].JAMA, 2002,288(23) : 2981.
  • 7Julius S,Kjeldsen SE,Weber M,et al.Outcomes in hypertensive Patients at high cardiovascular risk treated with valsartan or amlodip inebased vegimens:VALUE ,a randomized trial[J].Lancet, 2004,363 (9426) :2022.
  • 8Poole-Wilson PA,Lubsen J,Kirwan BA,et al. Effect of long acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiting treatment(ACTION trial) :randomized controlled trial[J].Lancet, 2004,364(9437) : 849.
  • 9Nissen SE,tuzey EM, Libby P,et al.Effect of antihypertensive agents on cardiovascular events in patients with coronary discase and normal blood pressure.The CAMELOT Study:a randomized controlled trial[J]. JAMA, 2004,292(18) : 2217.
  • 10张莉莉,张静华.我院抗菌药物用药调查与分析[J].中国药房,1995,6(3):20-21. 被引量:17

共引文献1918

同被引文献28

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部